sub field
BiotechGenomicsLongevity
About
Scott Gies is the CEO of Zoe Biosciences, a longevity-focused biotech developing therapies for cardiometabolic aging and age-related disease. Public company and project materials describe him as a founder of Zoe and note prior roles advising Longevity Vision Fund, leading business development and strategic partnerships at Flow Research Collective, and serving on the scientific diligence team at OS Fund. His background spans neuroscience, genetics, epigenetics, and longevity therapeutics.
Areas of interest
longevitybiotechaging therapeuticscardiometabolic diseasedrug discoveryneurosciencegeneticsepigenetics